title: Catecholaminergic polymorphic ventricular tachycardia.
authors.affiliation: AP-HP, Hôpital Bichat, Service de Cardiologie et Centre de Référence des Maladies Cardiaques Héréditaires, Paris, France. antoine.leenhardt@bch.aphp.fr
authors.forename: Antoine
authors.initials: A
authors.lastname: Leenhardt
authors.forename: Isabelle
authors.initials: I
authors.lastname: Denjoy
authors.forename: Pascale
authors.initials: P
authors.lastname: Guicheney
mesh_terms: D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D000818:Animals; D000889:Anti-Arrhythmia Agents / Q000627:therapeutic use; D002155:Calsequestrin / Q000235:genetics; D017147:Defibrillators, Implantable; D004562:Electrocardiography; D005424:Flecainide / Q000627:therapeutic use; D006801:Humans; D009154:Mutation; D010641:Phenotype; D019837:Ryanodine Receptor Calcium Release Channel / Q000235:genetics; D013562:Sympathectomy; D017180:Tachycardia, Ventricular / Q000175:diagnosis / Q000235:genetics* / Q000503:physiopathology / Q000628:therapy; D014700:Verapamil / Q000627:therapeutic use; D000098850:Polymorphic Catecholaminergic Ventricular Tachycardia
chemical_list: D000319:Adrenergic beta-Antagonists; D000889:Anti-Arrhythmia Agents; C443109:CASQ2 protein, human; D002155:Calsequestrin; D019837:Ryanodine Receptor Calcium Release Channel; C514388:casq2 protein, mouse; D014700:Verapamil; D005424:Flecainide